The Gross Margin of Apellis Pharmaceuticals Inc (APLS) is 84.93%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 84.93% |
| 2023-12-31 | 85.25% |
| 2022-12-31 | 92.57% |
| 2021-12-31 | 92.19% |
| 2020-12-31 | 90.02% |